Biopharma Insights - page 21

Technology Meets Biology in Canada

Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) …

Continue ›››

The Promise of DAOs in Drug Discovery

In August, Pfizer announced it requested to join VitaDAO with a half-a-million bid. VitaDAO is a new type of decentralized autonomous organization (DAOs) built on blockchain technology. DAOs are new …

Continue ›››

A Market Review of DNA-encoded Libraries Technology in Drug Discovery

(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal …

Continue ›››

First-of-its-kind AI-based Diagnostics Solutions Approved in Europe

According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 - nearly every 6th death worldwide happens because …

Continue ›››

A Race For Better 3CL Inhibitors to Cure COVID-19: Copies vs. Innovators

Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related to research and development and is not intended for clinical …

Continue ›››

Current Trends in Nanomedicine: Notable FDA Approvals and Clinical Trials to Follow

Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. But is “nano” defined just by the size? According to …

Continue ›››

Building Momentum for Global AI-driven Longevity Transformation

10 Life Science Blogs To Follow in 2022

(This article was originally published in 2020 and updated in August 2022) Reading life science blogs is a good way to combine leisure and expand one's professional expertise. They often …

Continue ›››

Toronto’s Blossoming AI-driven Drug Discovery Scene

Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep into the history of early programs and funding provided by …

Continue ›››

3D Printed Muscle Tissues for Drug Discovery With Mantarray™ Platform by Curi Bio

Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue contractility …

Continue ›››

Transformational EGFR Drug Discovery

Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality globally. Non-small-cell lung cancer (NSCLC) accounts for the majority of …

Continue ›››

AI-powered Cryo-EM Attracts Big Bucks And Promises To Disrupt Structural Biology

Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet tech giant ByteDance last October. Shuimu uses not only cutting-edge …

Continue ›››